0001062993-23-022645.txt : 20231215
0001062993-23-022645.hdr.sgml : 20231215
20231215164848
ACCESSION NUMBER: 0001062993-23-022645
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231213
FILED AS OF DATE: 20231215
DATE AS OF CHANGE: 20231215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Spandow Oliver J.
CENTRAL INDEX KEY: 0001749836
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32288
FILM NUMBER: 231491055
MAIL ADDRESS:
STREET 1: C/O 380 LACKAWANNA PLACE
CITY: SOUTH ORANGE
STATE: NJ
ZIP: 07079
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEPHROS INC
CENTRAL INDEX KEY: 0001196298
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 133971809
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 380 LACKAWANNA PLACE
CITY: SOUTH ORANGE
STATE: NJ
ZIP: 07079
BUSINESS PHONE: 201.343.5202
MAIL ADDRESS:
STREET 1: 380 LACKAWANNA PLACE
CITY: SOUTH ORANGE
STATE: NJ
ZIP: 07079
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-12-13
0001196298
NEPHROS INC
NEPH
0001749836
Spandow Oliver J.
C/O NEPHROS, INC.
380 LACKAWANNA PLACE
SOUTH ORANGE
NJ
07079
1
0
0
0
0
Common Stock
2023-12-13
4
A
0
14294
0
A
81604
D
Stock Option (Right to Buy)
5.5755
2028-08-10
Common Stock
9466
9466
D
Stock Option (Right to Buy)
5.8500
2028-12-19
Common Stock
5161
5161
D
Stock Option (Right to Buy)
8.5700
2029-12-16
Common Stock
5568
5568
D
Stock Option (Right to Buy)
8.0600
2031-01-06
Common Stock
6850
6850
D
Stock Option (Right to Buy)
6.82
2031-12-14
Common Stock
7062
7062
D
Stock Option (Right to Buy)
1.07
2032-01-05
Common Stock
7080
7080
D
Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors for 2023. These shares of restricted stock vest 6 months following the grant date.
Fully exercisable.
This option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23.
This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25.
/s/ Christopher Melsha as attorney-in-fact for Oliver Spandow pursuant to power of attorney previously filed.
2023-12-15